Garetatug
Garetatug is a humanized monoclonal antibody targeting human CLDN18 (claudin-18) . Garetatug specifically binds to CLDN18, interfering with relevant cell signaling pathways and exerting antitumor activity[1].
Product Specifications
CAS Number
[3023285-05-1]
UNSPSC
12352203
Target
Claudin
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Garetatug]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CLDN18
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
